Investors flee COVID pill drugmaker on report tying treatment to birth defects

Still, rival Covid treatments also carry risks for pregnant women but have been approved for use. Read More

Read More?

Post is imported from RSS feed, by one of our guest editors. G6 does not edit or moderate the content. G6 is not responsible for your actions. No rights owned by G6. To remove the post, please email us at [email protected]

No Comments

Sorry, the comment form is closed at this time.